Edwards Lifesciences Corp share price logo

Edwards Lifesciences Corp

NYSE: EW

Large Cap

$82.98

-0.35

(-0.42%)

as on

Edwards Lifesciences Corp Stock Performance

as on May 6, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $81.42
    $83.95
    downward going graph

    1.88%

    Downside

    1.17%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $72.30
    $87.89
    downward going graph

    12.87%

    Downside

    5.92%

    Upside

    downward going graph

Edwards Lifesciences Corp share price movements today

Previous Close
$83.33
Open
$83.03
Volume
2.4M
Day's Low - High
$81.42 - $83.95
52 Week Low - High
$72.30 - $87.89

Edwards Lifesciences Corp Historical Returns

1 Month Return
+ 2.12 %
3 Month Return
+ 5.34 %
1 Year Return
+ 10.66 %
3 Year Return
-6.57 %
5 Year Return
-9.63 %

Edwards Lifesciences Corp Stock Fundamentals & Key Indicators

Check Edwards Lifesciences Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$47.8B

EPS (TTM)

3.0062

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.08%

PE Ratio (TTM)

44.82

Industry PE ratio

37.11909090909091

PEG Ratio

2.0492

EBITDA

1.9B

Revenue (TTM)

6.3B

Profit Margin

17.39%

Return On Equity TTM

10.35%

Edwards Lifesciences Corp Stock Valuation

Track how Edwards Lifesciences Corp P/E has moved over time to understand its valuation trends.

Edwards Lifesciences Corp in the last 5 years

  • Overview

  • Trends

Lowest (26.71x)

December 31, 2024

Industry (37.12x)

May 6, 2026

Today (44.82x)

May 6, 2026

Highest (52.31x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: 44.82x

Edwards Lifesciences Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Edwards Lifesciences Corp with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$47.8B-9.63%44.8217.39%
BUY$83.2B30.07%23.4217.29%
BUY$113.1B16.18%35.1113.21%
BUY$99.9B-38.89%21.7313.00%
BUY$151.8B-26.62%24.4213.90%

Stock Returns calculator for Edwards Lifesciences Corp Stock including INR - Dollar returns

The Edwards Lifesciences Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Edwards Lifesciences Corp investment value today

Current value as on today

₹1,25,192

Returns

₹25,192

(+25.19%)

Returns from Edwards Lifesciences Corp Stock

₹10,758 (+10.76%)

Dollar Impact

₹14,434 (+14.43%)

Analyst Recommendation on Edwards Lifesciences Corp Stock

Based on 40 analysts

BUY

60.00%

Buy

35.00%

Hold

5.00%

Sell

Based on 40 analysts, 60% of analysts recommend a 'BUY' rating for Edwards Lifesciences Corp. Average target price of $97.15

Edwards Lifesciences Corp Share Price Target

Get share price movements and forecasts by analysts on Edwards Lifesciences Corp.

What analysts predicted

14.59%UPSIDE

Target Price

$97.15

Current Price

$82.98

Analyzed by

40 Analysts

Target

$97.15

Edwards Lifesciences Corp target price $97.15, a slight upside of 14.59% compared to current price of $82.98. According to 40 analysts rating.

Edwards Lifesciences Corp Stock’s Investor Sentiment and Interest

Search interest for Edwards Lifesciences Corp Stock has increased by 192% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:192% versus previous 30 day period

Edwards Lifesciences Corp Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
1,266
1,329
1,385
1,354
1,385
1,412
1,532
1,553
1,569
1,648
Gross Profit
1,015
1,040
1,088
1,091
1,093
1,111
1,189
1,209
1,229
1,289
Operating Income
356
355
364
350
312
394
430
425
370
514
EBITDA
403
409
426
428
483
470
400
387
133
514
Interest Expense
27
-
-
-
-
-
-
-
-
-
Depreciation
36
38
39
34
42
36
38
39
42
-
Income Before Tax
367
371
386
402
390
433
400
348
90
459
Income Tax Expense
34
46
20
40
45
70
64
56
26
78
Net Income
369
351
363
3,070
385
358
329
291
91
380
Net Profit Margin
29.21%
26.46%
26.24%
226.73%
27.83%
25.34%
21.52%
18.74%
5.81%
23.09%

Edwards Lifesciences Corp Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
2,963
3,435
3,722
4,348
4,386
5,232
5,382
6,004
5,439
6,067
Gross Profit
2,157
2,552
2,800
3,192
3,287
4,006
4,215
4,625
4,322
4,740
Operating Income
815
1,010
1,092
1,197
1,296
1,610
1,702
1,534
1,378
1,636
EBITDA
827
1,140
872
1,308
1,074
1,890
1,960
1,534
1,723
1,429
Interest Expense
18
23
33
27
22
24
26
17
19
20
Depreciation
-
81
77
89
107
134
139
143
155
156
Income Before Tax
737
1,034
761
1,166
916
1,702
1,767
1,598
1,548
1,272
Income Tax Expense
168
451
39
119
93
198
245
198
152
216
Net Income
569
622
722
1,046
823
1,503
1,521
1,402
4,174
1,073
Net Profit Margin
19.22%
18.11%
19.40%
24.08%
18.77%
28.73%
28.28%
23.35%
76.75%
17.69%

Edwards Lifesciences Corp Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
369
351
365
3,069
356
358
331
290
91
Operating Cash Flow
136
-53
371
351
280
280
290
573
450
Investing Cash Flow
14
63
124
2,701
85
85
-172
-427
-198
Financing Cash Flow
-413
61
-96
-976
-258
-258
52
-740
-11
Change in Cash
-265
81
429
2,035
90
90
141
-595
244

Edwards Lifesciences Corp Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
583
722
1,046
823
1,503
1,521
1,402
4,169
1,069
Operating Cash Flow
1,000
926
1,179
1,054
1,732
1,218
895
542
1,595
Investing Cash Flow
-647
76
-595
-531
-1,722
252
173
2,312
-712
Financing Cash Flow
-473
-1,101
-115
-486
-356
-1,584
-711
-983
-956
Change in Cash
-111
-104
465
15
-332
-94
375
1,910
-119

Mutual Funds that own Edwards Lifesciences Corp Stock

Check out the Mutual Funds with significant holdings in Edwards Lifesciences Corp.

Funds
Holdings
Shares Held
Motilal Oswal S&P 500 Index Fund Direct Growth
Motilal Oswal S&P 500 Index Fund Direct Growth
0.08282%
4334

Global Institutional Holdings in Edwards Lifesciences Corp

Funds
Holdings
Legal & General Group PLC
0.77%
Citadel Advisors Llc
0.38%
HSBC Holdings PLC
0.38%
Northern Trust Corp
1.05%
Geode Capital Management, LLC
2.22%

Edwards Lifesciences Corp News & Key Events

  • img

    Today's Timeline - 24 April

    Fri, 11:49 PM

    -

    Edwards Lifesciences reports Q1 2026 EPS of 78 cents, exceeding estimates, with sales of $1.65 billion.

Insights on Edwards Lifesciences Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Edwards Lifesciences Corp. has shown strong performance in its net profit over the last two quarters. The company's net profit increased significantly from $91.2 million to $380.7 million, averaging a rise of 76.0% each quarter.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Edwards Lifesciences Corp. has shown consistent revenue growth over the last 7 quarters. Their revenue increased from $1.35 billion to $1.64 billion, reflecting an average growth rate of 3.2% per quarter.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, EW has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, EW stock has moved up by 5.3%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, EW has outperformed top 5 stocks with highest market-cap in its industry

About Edwards Lifesciences Corp

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
OrganisationEdwards Lifesciences Corp
HeadquartersOne Edwards Way, Irvine, CA, United States, 92614
IndustryMedical Devices
CEOMr. Bernard J. Zovighian
E-voting on sharesClick here to vote

Key Management of Edwards Lifesciences Corp

Name

Title

Mr. Scott B. Ullem

Corporate VP & CFO

Ms. Annette Maria Bruls

Corporate Vice President of EMEA, Canada, & Latin America

Mr. Andrew M. Dahl

Principal Accounting Officer, Senior VP & Corporate Controller

Dr. Todd Brinton FACC, M.D.

Corporate VP of Advanced Innovation & Technology and Chief Scientific Officer

Mr. Bernard J. Zovighian

CEO & Director

Mr. Daveen Chopra

Corporate Vice President of Transcatheter Mitral & Tricuspid Therapies

Mr. Joseph Nuzzolese

Corporate Vice President of Global Operations & Quality

Mr. Snehashish Sarkar

Senior VP and Chief Information & Digital Officer

Mr. Mark D. Peterson

Corporate VP & General Counsel

Mr. Donald E. Bobo Jr.

Corporate Vice President of Strategy & Corporate Development

FAQs

What is Edwards Lifesciences Corp share price today?

Edwards Lifesciences Corp share price today is $82.98 as on at the close of the market. Edwards Lifesciences Corp share today touched a day high of $83.95 and a low of $81.42.

What is the 52 week high and 52 week low for Edwards Lifesciences Corp share?

Edwards Lifesciences Corp share touched a 52 week high of $87.89 on and a 52 week low of $72.3 on . Edwards Lifesciences Corp stock price today i.e. is closed at $82.98,which is 5.59% down from its 52 week high and 14.77% up from its 52 week low.

What is Edwards Lifesciences Corp's market capitalisation today?

Edwards Lifesciences Corp market capitalisation is $0.05T as on .

How to invest in Edwards Lifesciences Corp Stock (EW) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Edwards Lifesciences Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Edwards Lifesciences Corp Shares that will get you 0.0181 shares as per Edwards Lifesciences Corp share price of $82.98 per share as on May 6, 2026 at 1:29 am IST.

What is the minimum amount required to buy Edwards Lifesciences Corp Stock (EW) from India?

Indian investors can start investing in Edwards Lifesciences Corp (EW) shares with as little as ₹95.28 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.80 in Edwards Lifesciences Corp stock (as per the Rupee-Dollar exchange rate as on ). Based on Edwards Lifesciences Corp share’s latest price of $82.98 as on May 6, 2026 at 1:29 am IST, you will get 0.1205 shares of Edwards Lifesciences Corp. Learn more about fractional shares .

What are the returns that Edwards Lifesciences Corp has given to Indian investors in the last 5 years?

Edwards Lifesciences Corp stock has given -9.63% share price returns and 28.83% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?